Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ayesha A. Motala"'
Publikováno v:
Global Health, Epidemiology and Genomics
There is a dearth of data on the burden and spectrum of non-alcoholic fatty liver disease (NAFLD) in African populations. The limited available information suggests that the prevalence of NAFLD in the general population is lowest for the Africa regio
Publikováno v:
South African Medical Journal. 109:963
Background. The reported prevalence of low testosterone among men with type 2 diabetes mellitus (T2DM) is high. However, there is a dearth of information on the prevalence of androgen deficiency symptoms and low serum testosterone levels in men with
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0149209 (2016)
PLoS ONE
PLoS ONE
Background There is a surge of cardiovascular disease (CVD) in Africa. CVD is the leading cause of mortality among patients with severe mental illness (SMI) in developed countries, with little evidence from the African context. Objective To determine
Autor:
Gershim Asiki, Fasil Tekola-Ayele, Stephen Tollman, Dominic P. Kwiatkowski, Eleftheria Zeggini, Adebowale Adeyemo, Manjinder S. Sandhu, Luca Pagani, Ayesha A. Motala, Charles N. Rotimi, Deepti Gurdasani, Kalifa Bojang, Tommy Carstensen, Yali Xue, Elizabeth H. Young, Anatoli Kamali, Savita Karthikeyan, Tamiru Oljira, Neil Bradman, Rebecca N. Nsubuga, Katja Kivinen, Muminatou Jallow, Janet Seeley, Fatoumatta Sisay-Joof, Jennifer L. Asimit, Ephrem Mekonnen, Louise Iles, Endashaw Bekele, Graham R. S. Ritchie, Ananyo Choudhury, Pontiano Kaleebu, Rosemary Ekong, Konstantinos Hatzikotoulas, Martin O. Pollard, Fraser J. Pirie, Michèle Ramsay, Shane A. Norris, K Rockett, Ayo P. Doumatey, Cristina Pomilla, Ioanna Tachmazidou, Chris Tyler-Smith
Publikováno v:
Europe PubMed Central
Given the importance of Africa to studies of human origins and disease susceptibility, detailed characterization of African genetic diversity is needed. The African Genome Variation Project provides a resource with which to design, implement and inte
Publikováno v:
Diabetes research and clinical practice. 103(2)
The Africa Region (AFR), where diabetes was once rare, has witnessed a surge in the condition. Estimates for type 1 diabetes suggest that about 39,000 people suffer from the disease in 2013 with 6.4 new cases occurring per year per 100,000 people in
Publikováno v:
Diabetes Care. 20:1101-1107
OBJECTIVE To evaluate the significance of transient impaired glucose tolerance (IGT) in terms of the risk of progression to NIDDM and the serum insulin response during oral glucose tolerance test (OGTT) in a prospective study on the natural history o
Publikováno v:
Ethnicitydisease. 19(2 Suppl 2)
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 20(1)
Aims Previous cross-sectional studies have established that South African Indians have a high prevalence of Type 2 diabetes mellitus. A prospective community study was undertaken to determine the incidence of Type 2 diabetes and the risk factors asso
Publikováno v:
Diabetes care. 15(10)
OBJECTIVE To assess the effect of insulin therapy on blood pressure in NIDDM patients with secondary failure. RESEARCH DESIGN AND METHODS The influence of insulin treatment on blood pressure was assessed retrospectively in a group of 80 NIDDM patient
Publikováno v:
BMC Psychiatry
Background Sub Saharan African is experiencing the largest increase in the prevalence of type 2 diabetes mellitus and cardiovascular disease globally. Metabolic syndrome (MetS) is a cluster of risk factors for these conditions. There is a consistentl